Website  I   Bio    Site Map   I    Contact 
Phoenix Rising

Making A Difference in ME/CFS
(Chronic Fatigue Syndrome) and FM

Get the Free Newsletter!
 Chronic Fatigue Syndrome (ME/CFS)
  • Asthma: $10 billion economic losses year
  • Asthma funding:$300 million a year
  • ME/CFS: $20 billion economic losses year
  • ME/CFS funding: $4 million a year

What You Can Do

Skip Navigation Links
ME/CFS
Home
FORUMS
What is ME/CFS?
Myths
Facts
Symptoms
Diagnosis
Treatment
FM
What is FM?
Myths
Facts
Symptoms
Diagnosis
Skip Navigation Links

RESEARCH

Get the FREE NEWSLETTER!
Like the Website?
Please

DONATE

XMRV Buzz

ME/CFS

Skip Navigation Links
Home
Basics
XMRV
Newsletter
Resources
Doctors
Disability
Blogs
Foundations
BooksExpand Books
Encounters With Invisible
Fatigued to Fantastic
Monkeys with Wings
Hope and Help
Scroll up
Scroll down
Treat
Doctor Visit!
SleepExpand Sleep
Problems StandingExpand Problems Standing
EnergyExpand Energy
AntiviralsExpand Antivirals
LivingExpand Living
Treatment PlansExpand Treatment Plans
Hygiene
AlternativesExpand Alternatives
DrugsExpand Drugs
Stress BustersExpand Stress Busters
Scroll up
Scroll down
Melatonin
Scroll up
Scroll down
Amytriptyline
Ambien
Klonopin
Xyrem
Optimizing
Scroll up
Scroll down
Aroma
Scroll up
Scroll down
Living With OI
DrugsExpand Drugs
Stimulants
Diet
Home Test
Resources
Scroll up
Scroll down
Florinef
Midodrine
Atenolol
Propanolol
'Erythro'
Scroll up
Scroll down
'Mito'Expand 'Mito'
Energy DrugsExpand Energy Drugs
Scroll up
Scroll down
D-Ribose
Glutathione
L-carnitine
FA's
CoQ10
Rhodiola
Scroll up
Scroll down
Adderall
Dexedrine
Provigil
Ritalin
Scroll up
Scroll down
Amantadine
Ampligen
Twisted History
Azithromycin
Interferon
Isoprinosine
Immunoglobulins
LDN
Nexavir
Oxymatrine
Valcyte
Valtrex
Vistide
Scroll up
Scroll down
Pacing
Meditation
Breathing
Hyperventilation
Body Scan
50% Solution
On A Budget
Scroll up
Scroll down
Cheney
Bateman
Pall
Blood Volume
Scroll up
Scroll down
Interviews
Research
Conferences
Advocacy
Editors Page
Stories
Website
Bio
Website

Overviews of Papers on RNase L

These papers chart the findings of studies examining RNase L's role in ME/CFS. Most were published after CFS ABA

  1. G-actin: A Screening Test for CFS?' (01)
  2.    
  3. 'A Channelopathy in CFS?'  (01) 
  4.      
  5. The Dynamics of RNase L Degradation' (02) 
  6.     
  7. Mycoplasmas and RNase L Fragmentation' (02)
  8.     
  9. Channelopathy - A First Study' (03)
  10.   
  11. An Overview from Patrick Englebienne' (03)
  12.      
  13. 'CFS Patients: Increased Risk of Weak Bones?' (03)
  14. ‘RNase L and Thyroid Dysfunction?’ (03) 
  15.         
  16. Breathing Difficulties and RNase L?'  (04)
  17.        
  18. A Landmark Paper?' (04)
  19.        
  20. Cracks in the Dike? (05)
  21.       
  22. Testing RNase L - A Biomarker for CFS?' (05)

Focus on the RNase L Enzyme: These papers provide a more complete understanding of RNase L

  1. 'More! RNase L' (90-00) - 2-5OAS activation/the 100 kDa isoform: An odd man out? And other possible consequences of RNase L dysregulation.
  2.      
  3. RNase L and PKR: A Vicious Circle? (03)
  4. Cellular Stress - A  Key Player in RNase L Dysfunction in CFS? (04)